| Application no. and date | 13175987.0 (espacenet) (Federated) (European Patent Register), 20070228 | | Patent/reg. no. and date | DK/EP 2676967, 20190814 | | Publication date | 20131225 | | Priority no. and date | US 776931 P, 20060228 | | EP pub. no. and date |
EP 2676967 20131225 | | Effective date | | | Applicant/owner | Biogen MA Inc., 225 Binney Street
Cambridge, MA 02142, US | | Applicant ref. no. | T5965_DK | | Inventor | LIEBERBURG, Ivan, 85 Hillcrest Road
Berkeley, CA 94705, US | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 38/03 (2006.01) , A61K 38/21 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 49/00 (2006.01) , C07K 16/28 (2006.01) , G01N 33/53 (2006.01) , G01N 33/68 (2006.01) | | Title | Fremgangsmåder til behandling af inflammatoriske og autoimmune sygdomme med natalizumab | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
